| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ENE.12303 |
| P698 | PubMed publication ID | 24433475 |
| P50 | author | Anthony H V Schapira | Q66915960 |
| P2860 | cites work | Mitochondrial fission proteins in peripheral blood lymphocytes are potential biomarkers for Alzheimer's disease | Q28260038 |
| Voxel-wise meta-analysis of gray matter abnormalities in idiopathic Parkinson's disease | Q33962478 | ||
| Conventional brain MRI in neuromyelitis optica | Q34062883 | ||
| One-year survival of demented stroke patients: data from the Dijon Stroke Registry, France (1985-2008). | Q34089381 | ||
| Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis | Q34089586 | ||
| Susac syndrome: clinical characteristics and treatment in 29 new cases | Q34119506 | ||
| Thrombolysis in cervical artery dissection--data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database | Q34208135 | ||
| The bidirectional relationship between headache and chronic musculoskeletal complaints: an 11‐year follow‐up in the Nord‐Trøndelag Health Study (HUNT) | Q47877793 | ||
| Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients | Q48176784 | ||
| Subjective sleep problems in patients with early Parkinson's disease | Q48235902 | ||
| Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. | Q48264930 | ||
| Sleep disturbances in chronic progressive external ophthalmoplegia | Q48289706 | ||
| Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease | Q48296473 | ||
| Quality of life after radiosurgery for cerebral arteriovenous malformation patients who present with seizure | Q48481260 | ||
| Steroid‐sparing effects of angiotensin‐II inhibitors in glioblastoma patients | Q48487650 | ||
| Detection of microbleeds in post-mortem brains of patients with frontotemporal lobar degeneration: a 7.0-Tesla magnetic resonance imaging study with neuropathological correlates. | Q48490898 | ||
| Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson's disease leads to improvement in caregivers' stress and burden. | Q48496658 | ||
| Health-related quality of life and depressive symptoms in significant others of people with multiple sclerosis: a community study | Q48499312 | ||
| Cervical artery dissection is not a benign entity in the thrombolytic era | Q48522901 | ||
| Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis | Q48525508 | ||
| Intravenous thrombolysis in ischaemic stroke secondary to cervical artery dissection: safe but not effective? | Q48547044 | ||
| Characteristics of stroke mechanisms in patients with medullary infarction | Q48554820 | ||
| Hemiplegia and thrombolysis | Q48558753 | ||
| Fatigue, depression, and health‐related quality of life in patients with multiple sclerosis in Isfahan, Iran | Q48578252 | ||
| Right‐to‐left shunts as a cause of juxtacortical spots in patients with migraine | Q48644337 | ||
| Disease severity affects quality of life of hereditary spastic paraplegia patients. | Q48658828 | ||
| Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. | Q48662769 | ||
| Nigral iron deposition occurs across motor phenotypes of Parkinson’s disease | Q48685391 | ||
| Carotid artery plaque progression and cognitive decline: the Tromsø Study 1994-2008. | Q48691354 | ||
| Magnetic resonance imaging abnormalities in children with epilepsy | Q48711666 | ||
| Evidence for epistatic gene interactions between growth factor genes in stroke outcome | Q48719254 | ||
| Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study | Q48726357 | ||
| Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. | Q48726404 | ||
| Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population‐based study | Q48726426 | ||
| Fatigue in early Parkinson's disease. Minor inconvenience or major distress? | Q48729304 | ||
| Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. | Q48729623 | ||
| Subjective cognitive complaints: not to be dismissed | Q48737112 | ||
| Cerebral artery calcification in patients with acute cerebrovascular diseases: determinants and long-term clinical outcome | Q48768324 | ||
| Depression after minor stroke: prevalence and predictors | Q48785653 | ||
| Good long-term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer-blinded study | Q48799571 | ||
| The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke | Q48840325 | ||
| Changes in cognitive‐emotional and physiological symptoms of depression following STN‐DBS for the treatment of Parkinson’s disease | Q48852717 | ||
| Recovery after stroke: more than just walking and talking again If you don't look for it, you won't find it. | Q48865491 | ||
| Radiopacity of intracerebral hemorrhage correlates with perihemorrhagic edema | Q48876250 | ||
| No increase in headache after previous intracranial infections: a historical cohort study (HUNT) | Q48876276 | ||
| Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage | Q48876329 | ||
| Significance of microbleeds in patients with transient ischaemic attack. | Q48876364 | ||
| Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis? | Q48902349 | ||
| Routine cardiac evaluation in patients with ischaemic stroke and absence of known atrial fibrillation or coronary heart disease: transthoracic echocardiography vs. multidetector cardiac computed tomography | Q48902362 | ||
| Continuous monitoring versus HOLTER ECG for detection of atrial fibrillation in patients with stroke | Q48914469 | ||
| Clinical and molecular genetic factors affecting postoperative seizure control of 183 Chinese adult patients with low-grade gliomas | Q48914486 | ||
| Apathy in acute stroke patients | Q48914505 | ||
| Pre-stroke use of beta-blockers does not affect ischaemic stroke severity and outcome | Q49025533 | ||
| A clinical profile of 103 patients with secondary movement disorders: correlation of etiology with phenomenology | Q49025560 | ||
| Regional cortical thickness and cognitive functions in non-demented Parkinson's disease patients: a pilot study | Q49032441 | ||
| White blood cell SPECT during active period of cluster headache and in remission | Q49032475 | ||
| Self-medication of regular headache: a community pharmacy-based survey | Q49032701 | ||
| Clinical characteristics of essential tremor in Taiwan: an exploratory-comparative study | Q50263722 | ||
| Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson’s disease | Q50528372 | ||
| The relationship between self‐reported executive performance and psychological characteristics in multiple sclerosis | Q50605172 | ||
| Neurobehçet disease: clinical and demographic characteristics | Q50762912 | ||
| Gesture comprehension, knowledge and production in Alzheimer’s disease | Q50768755 | ||
| Early-stage cognitive impairment in Parkinson's disease and the influence of dopamine replacement therapy | Q50781502 | ||
| Increased incidence of Guillain-Barré syndrome after surgery. | Q50950339 | ||
| European neuroborreliosis: neuropsychological findings 30 months post-treatment | Q50987766 | ||
| Neuropsychological outcome after a first symptomatic ischaemic stroke with 'good recovery'. | Q51006444 | ||
| Optimizing the risk estimation after a transient ischaemic attack - the ABCDE⊕ score | Q51034968 | ||
| Tick‐borne encephalitis in Latvia 1973–2009: epidemiology, clinical features and sequelae | Q51164431 | ||
| Incidence of childhood and adolescence epilepsy: a community-based prospective study in the province of Ferrara and in Copparo, Italy, 1996-2005. | Q51169628 | ||
| Reduced urinary glutamate levels are associated with the frequency of migraine attacks in females | Q51181390 | ||
| A national epidemiological study of Myasthenia Gravis in Australia | Q51182046 | ||
| Muscle MRI in female carriers of dystrophinopathy. | Q51339958 | ||
| Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population | Q51358335 | ||
| Somatic neuropathy is an independent predictor of all‐ and diabetes‐related mortality in type 2 diabetic patients: a population‐based 5‐year follow‐up study (KCIS No. 29) | Q51361852 | ||
| Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica | Q51432839 | ||
| Telomere length shortening in patients with dementia with Lewy bodies | Q51434882 | ||
| Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity. | Q51458905 | ||
| Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort | Q51483415 | ||
| An intravenous insulin protocol for strict glycemic control in acute ischaemic stroke | Q51515586 | ||
| Is there a future for neuroprotective agents in acute ischaemic stroke? | Q51639255 | ||
| Deep Brain Stimulation in Pantothenate Kinase Associated Neurodegeneration: challenges for the future | Q51659810 | ||
| Pantothenate kinase-associated neurodegeneration in Korea: recurrent R440P mutation in PANK2 and outcome of deep brain stimulation | Q53141394 | ||
| A genotype-phenotype analysis of the 8q22.1 variant in migraine with aura | Q53141399 | ||
| Off-label intravenous thrombolysis in acute stroke. | Q53146655 | ||
| Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial | Q53181176 | ||
| A population‐based case–control study of 1250 stroke deaths in rural Bangladesh | Q53680013 | ||
| Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients. | Q54311380 | ||
| Fabry disease in unselected patients with TIA or stroke: population-based study. | Q54312694 | ||
| CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. | Q54330074 | ||
| Association study of functional polymorphisms in serotonin transporter gene with temporal lobe epilepsy in Han Chinese population | Q54346432 | ||
| Association of haplotype combination of serotonin transporter gene polymorphisms with monthly headache days in MOH patients. | Q54372608 | ||
| Trauma and amyotrophic lateral sclerosis: a case–control study from a population‐based registry | Q56839376 | ||
| Earthquakes and neurological care | Q57106816 | ||
| Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15 | Q57224331 | ||
| Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control study | Q57259062 | ||
| Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid | Q57306451 | ||
| Reassessing received wisdom in ALS – pain is common when studied systematically | Q57357887 | ||
| Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response | Q57601861 | ||
| Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis | Q59149662 | ||
| Relationship of initial glucose level and all-cause death in patients with ischaemic stroke: the roles of diabetes mellitus and glycated hemoglobin level | Q83360221 | ||
| Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data | Q34320218 | ||
| Cerebral microbleeds and white matter disease: separated at birth? | Q35421540 | ||
| Glucose metabolism in sporadic Creutzfeldt–Jakob disease: a statistical parametric mapping analysis of 18F‐FDG PET | Q35748425 | ||
| Increased number of Purkinje cell dendritic swellings in essential tremor | Q35815619 | ||
| Treatment for Helicobacter pylori infection and risk of parkinson’s disease in Denmark | Q35899185 | ||
| Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia | Q35957307 | ||
| Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer’s disease | Q35957378 | ||
| Color vision: a study of essential tremor cases versus normal controls | Q36037354 | ||
| Estrogen in ischaemic stroke: the debate continues | Q36157178 | ||
| Depressive traits in essential tremor: impact on disability, quality of life, and medication adherence | Q36210177 | ||
| Move for change part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's disease | Q36371466 | ||
| Measuring quality of life impairment in skeletal muscle channelopathies. | Q36382734 | ||
| Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings | Q37883488 | ||
| A literature review of the pathophysiology and onset of post-stroke spasticity | Q37894853 | ||
| PET in coma and in vegetative state | Q37907382 | ||
| The role of intima‐media‐thickness, ankle‐brachial‐index and inflammatory biochemical parameters for stroke risk prediction: a systematic review | Q37927179 | ||
| EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force | Q37931374 | ||
| UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden? | Q37939477 | ||
| Nocebo in fibromyalgia: meta‐analysis of placebo‐controlled clinical trials and implications for practice | Q37942656 | ||
| Five‐year experience with incobotulinumtoxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins | Q37950432 | ||
| Recurrent Miller Fisher syndrome: clinical and laboratory features | Q37960934 | ||
| The cost of headache disorders in Europe: the Eurolight project | Q37963926 | ||
| Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic restless legs syndrome patients. | Q37969177 | ||
| IV Valproate in generalized convulsive status epilepticus: a systematic review. | Q37969825 | ||
| Narcolepsy and sleep-disordered breathing. | Q37969828 | ||
| Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson's disease | Q37973462 | ||
| Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. | Q37976113 | ||
| Treatment for dystonia in childhood | Q37979912 | ||
| Levodopa/carbidopa intestinal gel infusion long‐term therapy in advanced Parkinson’s disease | Q37987615 | ||
| Retrospective case series of outcomes following spinal cord infarction | Q37995641 | ||
| The role of corticosteroids in the management of chronic subdural hematoma: a systematic review | Q38014075 | ||
| EFNS‐ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system | Q38033652 | ||
| EFNS task force: the use of neuroimaging in the diagnosis of dementia. | Q38035398 | ||
| European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society | Q38039480 | ||
| ATXN8 −62 G/A promoter polymorphism and risk of Taiwanese Parkinson's disease | Q38325447 | ||
| Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease | Q38470835 | ||
| Prefrontal cortex rTMS enhances action naming in progressive non-fluent aphasia. | Q38474328 | ||
| The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease. | Q38475592 | ||
| How subjective are subjective language complaints | Q38477870 | ||
| Exposure to environmental toxins and the risk of sporadic motor neuron disease: an expanded Australian case-control study | Q39612026 | ||
| Surgical therapy for multiple sclerosis tremor: a 12-year follow-up study | Q39664090 | ||
| Adverse life event and risk of cognitive impairment: a 5‐year prospective longitudinal study in Chongqing, China | Q39680119 | ||
| Pain in amyotrophic lateral sclerosis: a population-based controlled study. | Q39700757 | ||
| Medical and non‐medical correlates of carpal tunnel syndrome in a Taiwan cohort of one million | Q39743761 | ||
| Low ankle–brachial index is a predictive factor for initial severity of acute ischaemic stroke | Q40018612 | ||
| Weekly IM interferon beta‐1a in multiple sclerosis patients over 50 years of age | Q42607316 | ||
| Meningoencephaloradiculomyelitis after tick‐borne encephalitis virus infection: a case series | Q42977197 | ||
| Serum cholesterol levels and survival after rtPA treatment in acute stroke | Q43415282 | ||
| Characterization of the Asian myopathy patients with VCP mutations | Q43488914 | ||
| Use of a handheld, computerized device as a decision support tool for stroke classification. | Q43539340 | ||
| Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia-eclampsia and other predisposing diseases | Q43569407 | ||
| Monthly variation of multiple sclerosis activity in the southern hemisphere: analysis from 996 relapses in Brazil | Q43591967 | ||
| Medial temporal lobe is vulnerable to vascular risk factors in men: a population-based study | Q43680213 | ||
| Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases. | Q43920314 | ||
| Isolated lateral thalamic infarction: the role of posterior cerebral artery disease | Q44119540 | ||
| Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population | Q44358768 | ||
| Off‐hours admission for acute stroke is not associated with worse outcome – a nationwide Israeli stroke project | Q44444539 | ||
| Functional MRI and motor behavioral changes obtained with constraint‐induced movement therapy in chronic stroke | Q44471492 | ||
| Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation | Q44523947 | ||
| Off-hour effects on stroke care and outcome in stroke centres | Q44547791 | ||
| Soluble VEGFR1 (sVEGFR1) as a novel marker of amyotrophic lateral sclerosis (ALS) in the North Indian ALS patients | Q44591767 | ||
| Incidence and prevalence of Parkinson's disease in Buenos Aires City, Argentina | Q44686122 | ||
| The phenomenon of ‘chronic Lyme’; an observational study | Q44711995 | ||
| Factors related to respiration influencing survival and respiratory function in patients with amyotrophic lateral sclerosis: a retrospective study | Q44788021 | ||
| The economic cost of brain disorders in Europe | Q44814293 | ||
| The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non‐hemorrhagic infarct, and non‐lesional venous stroke in patients with cerebral sinus–venous thrombosis | Q44890205 | ||
| Improving the assessment of TIAs [corrected]. | Q44893826 | ||
| The powerful pre‐treatment effect: placebo responses in restless legs syndrome trials | Q44913262 | ||
| Incidence and survival of symptomatic lacunar infarction in a Beijing population: a 6‐year prospective study | Q44915669 | ||
| What is the expert's option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey | Q44995283 | ||
| EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. | Q45289583 | ||
| MRI-based intravenous thrombolysis in stroke patients with unknown time of symptom onset | Q45327670 | ||
| Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke? | Q45339312 | ||
| Dementia quality of life instrument--construct and concurrent validity in patients with mild to moderate dementia. | Q45853606 | ||
| Estradiol levels predict short‐term adverse health outcomes in postmenopausal acute stroke women | Q45888037 | ||
| Correlation between genetic polymorphisms and stroke recovery: analysis of the GAIN Americas and GAIN International Studies. | Q45961668 | ||
| The prevalence of neuromyelitis optica in South East Wales. | Q46030283 | ||
| Association of non‐diabetic hyperglycemia with autonomic shift in acute ischaemic stroke | Q46234084 | ||
| Sex differences in perihemorrhagic edema evolution after spontaneous intracerebral hemorrhage | Q46371722 | ||
| Cognitive and affective impairments of a novel SCA/MND crossroad mutation Asidan | Q46399610 | ||
| Artistic productivity and creative thinking in Parkinson's disease. | Q46563951 | ||
| High anti‐EBNA‐1 IgG levels are associated with early‐onset myasthenia gravis | Q46763001 | ||
| Age‐ and weight‐adjusted warfarin initiation nomogram for ischaemic stroke patients | Q47305494 | ||
| Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial | Q47321677 | ||
| Prevalence and extent of right‐to‐left shunt in migraine: a survey of 217 Chinese patients | Q47433630 | ||
| Zurich Fabry study – prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA | Q47648317 | ||
| The prediction of 30‐day mortality in patients with primary pontine hemorrhage: a scoring system comparison | Q47868393 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1499-1507 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | European Journal of Neurology | Q15757256 |
| P1476 | title | Progress in European neurology 2012-2013. | |
| P478 | volume | 20 |
| Q39085317 | New hospital structure in the twenty-first century: the position of level III (tertiary) neurological and stroke care in a changing healthcare system | cites work | P2860 |
Search more.